Misplaced Pages

This article contains promotional content. Please help improve it by removing promotional language and inappropriate external links, and by adding encyclopedic text written from a neutral point of view. (July 2018) (Learn how and when to remove this message)

BrainScope Company, Inc. (BrainScope) is a medical neuro-technology firm utilizing EEG technology to assess the full spectrum of mild traumatic brain injury (mTBI), including functional injuries (such as a concussion), and structural injuries (such as a brain bleed). BrainScope was founded in 2006 and is headquartered in Bethesda, Maryland.

BrainScope's markets include the military, emergency departments, urgent care clinics, and both collegiate and professional-level sports programs.

Technology

BrainScope is a multimodal medical device that provides clinicians with the ability to identify structural and functional mild traumatic brain injuries (mTBIs) in their patients, such as brain bleeds and concussions. It uses electroencephalographic data, artificial intelligence, machine learning technology, cognitive performance and clinical assessments to help identify mTBIs.

The electroencephalographic data that is collected with a disposable electrode headset provides objective biomarkers to both predict the likelihood that a patient's structural brain injury would be visible on a CT scan and assess the likelihood of functional impairment in the brain by comparing the patient's brain function to that of non-head injured individuals. BrainScope also uses neurocognitive tests (Procedural Reaction Time & Match to Sample), which are performed by the patient on the device, as well as using a library of digitized concussion assessments.

An independent validation trial conducted using BrainScope determined that the device's sensitivity to "≥1 mL of blood was ... 98.6%" and that its accurate CT-scan predictions can lead to a "potential reduction in the number of head C.T. scans in the Emergency Department by 31%."

BrainScope's technology was created through 28 clinical studies at over 90 clinical sites spanning over a decade, contributing to 32 investigator-initiated peer-review journal articles and resulting in eight FDA clearances. BrainScope is FDA cleared as an Rx-only device for use on patients 18–85 years of age who have suffered a mild head injury GCS (Glasgow Coma Scale score of 13-15 and mTBI) within the previous 72 hours for its Structural Injury Classifier (SIC) and Brain Function Index (BFI) algorithms. The Concussion Index algorithm is FDA cleared for use on patients 13–25 years of age with a GSC score of 15 and can be used with 72 hours of acute injury, for baseline and throughout recovery. BrainScope was originally cleared by the FDA as the Ahead 300 under 510(k) K161068 in September 2016. Subsequent modifications to device Indications for Use regarding concussion/mTBI capabilities were FDA cleared under 510(k) K181179 in May 2018.

The company initiated a clinical research study on patients 13–25 years of age in May 2018 as part of its initiative to "introduce a teenage-focused product in the near-term."

Partners

BrainScope has raised over $60 million in private capital and has received $30 million in research contracts, including funding from the United States Department of Defense and General Electric and the National Football League through their Head Health Challenge competition. Among the company's private investors are Revolution LLC, an investment firm founded by AOL co-founder Steve Case; DBL Partners, a venture capital firm that also backs Tesla and Pandora; and the Maryland Venture Fund.

BrainScope's other development partners include New York University School of Medicine and Johns Hopkins University, and its clinical partners include Emory University, the University of Virginia and Washington University in St. Louis.

Awards

• Winner of the 2017 Frost & Sullivan Best Practices Award - Traumatic Brain Injury New Product Innovation
• Finalist for the 2017 Prix Galien Foundation USA Award for Best Medical Technology Product
• Greater Washington Health & Life Sciences 2017 Innovator of the Year
• Winner of the 2017 Moxie Award for Healthcare
• Maryland Emerging Life Science 2016 Business of the Year
• Two-time winner of the GE NFL Head Health Challenge, 2014 and 2015
• 2012 Montgomery County Chamber of Commerce Verl Zanders Emerging Business of the Year

References

1. "Medics start using scanner that could detect TBI earlier". Stars and Stripes. Retrieved 2018-06-25.
2. ^ Olivas, Denise (2017-07-27). "UMC uses new equipment for brain care". KVIA. Retrieved 2018-06-25.
3. ^ Orcutt, Mike. "Is This the Diagnostic Tool We've Been Waiting for in Concussion Testing?". MIT Technology Review. Retrieved 2018-06-25.
4. Hanley, Daniel; Prichep, Leslie S.; Bazarian, Jeffrey; Huff, J. Stephen; Naunheim, Rosanne; Garrett, John; Jones, Elizabeth B.; Wright, David W.; O'Neill, John (2017-03-31). "Emergency Department Triage of Traumatic Head Injury Using a Brain Electrical Activity Biomarker: A Multisite Prospective Observational Validation Trial". Academic Emergency Medicine. 24 (5): 617–627. doi:10.1111/acem.13175. ISSN 1069-6563. PMID 28177169.
5. Huff, J. Stephen; Naunheim, Rosanne; Ghosh Dastidar, Samanwoy; Bazarian, Jeffrey; Michelson, Edward A. (2017). "Referrals for CT scans in mild TBI patients can be aided by the use of a brain electrical activity biomarker". The American Journal of Emergency Medicine. 35 (11): 1777–1779. doi:10.1016/j.ajem.2017.05.027. ISSN 0735-6757. PMID 28579138.
6. "US firm launches device to rapidly diagnose concussion". The Irish Times. Retrieved 2018-07-10.
7. "510(k) Premarket Notification". www.accessdata.fda.gov. Retrieved 2018-06-27.
8. "510(k) Premarket Notification". www.accessdata.fda.gov. Retrieved 2018-06-27..
9. "BrainScope Initiates Teenage and Young Adult Multi-Site Clinical Study for Concussion Assessment Product". Retrieved 2018-06-20.. This study was for the company's third algorithm, the Concussion Index.
10. "Whitman High School Chosen for Concussion Research Study". Retrieved 2018-06-25.
11. ^ Heath, Thomas (2015-07-23). "Bethesda's BrainScope scores $500k from NFL, General Electric". Washington Post. ISSN 0190-8286. Retrieved 2018-06-13.
12. "Term Sheet -- Thursday, August 31". Fortune. Retrieved 2018-06-25.
13. "Portfolio | DBL Partners". www.dblpartners.vc. Retrieved 2018-06-14.
14. "BrainScope Completes $16 Million Equity Fundraise". Retrieved 2018-06-13.
15. "Quickly assessing brain bleeding in head injuries using new device". ScienceDaily. Retrieved 2018-06-25.
16. Bernhard, Blythe. "Working to prevent, diagnose concussions in kids". stltoday.com. Retrieved 2018-06-25.
17. "BrainScope Receives Frost & Sullivan Best Practices Award in Traumatic Brain Injury Assessment". Retrieved 2018-06-26.
18. Foundation, The Galien. "The Galien Foundation Debuts 2017 Prix Galien USA Nominees in "Best Biotechnology Product," "Best Pharmaceutical Product," and "Best Medical Technology" Categories". www.prnewswire.com (Press release). Retrieved 2018-06-13.
19. "2017 Greater Washington Innovation Awards winners and finalists announced". INSIDENOVA.COM. Retrieved 2018-06-14.
20. "Moxie Award 2017 Winners - Moxie Award". Moxie Award. Retrieved 2018-06-25.
21. "Business Notes: Bethesda Firm Named Emerging Life Science Business of the Year". Retrieved 2018-06-14.
22. "NFL, GE announce six final winners of Head Health Challenge I". NFL.com. Archived from the original on May 12, 2017. Retrieved 2018-06-26.
23. "BrainScope Company, Inc. Awarded Montgomery County Emerging Business of the Year | BioSpace". BioSpace. Retrieved 2018-06-25.

• Biotechnology companies of the United States